SimBioSys Gets FDA Clearance for AI Breast Cancer Recurrence Tool
Oct 15, 2026
Biotech
SimBioSys and Ferrum Health Partner to Expand Access to AI Surgical Planning Tools
Jul 23, 2026
SimBioSys has partnered with Ferrum Health to make its FDA-cleared TumorSight Viz platform available through Ferrum's Model Hub, improving deployment and management of AI surgical planning capabilities across U.S. health systems.
SimBioSys has partnered with Ferrum Health to broaden access to its FDA-cleared TumorSight Viz platform through Ferrum's Model Hub, announced in a press release.
TumorSight Viz converts standard breast MRI scans into patient-specific 3D visualizations to assist surgeons in planning procedures. Through integration with Ferrum’s Model Hub, hospitals can deploy and manage the tool within existing infrastructure, enabling centralized oversight, monitoring, and scalability across clinical environments.
Ferrum’s platform supports the deployment of AI applications across healthcare systems, while TumorSight Viz brings a focus on breast surgical planning by generating anatomy-specific visualizations. The companies intend to accelerate access to these AI tools in more institutions, enhancing the ability of surgeons to make informed, context-rich decisions during surgical planning.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Nov 13 ETR survey: Claude leads enterprise AI tools on satisfaction and spending plans Nov 13 Peter Sarlin's PostScriptum takes majority stake in Finnish AI deployment firm Brillian Nov 13 Gondola says Codex lifted engineering output 25% as revenue more than doubled Nov 13 DuPont teams with Microsoft and NobleAI to speed up R&D with AI Nov 13 Korean AI startups fear Huang exit could delay planned NVIDIA investmentsMore from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
.png)
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Avenda Health Brings Unfold AI Maps Into Prostate Surgery
Oct 21, 2026
Healthcare
NVIDIA Debuts RFD4-Proteina and Expands Radiotherapy Work
Oct 21, 2026
Biotech
Azra AI Acquires Blackford Analysis
Oct 20, 2026
Acquisitions
Atlas Bio raises $12.5 million for virtual drug trials
Oct 27, 2026
Healthcare
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
Oct 14, 2026
Healthcare
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.